The estimated Net Worth of Bruce Turner is at least $612 Тысяча dollars as of 2 October 2023. Bruce Turner owns over 42,300 units of Immunome stock worth over $611,658 and over the last few years Bruce sold IMNM stock worth over $0.
Bruce has made over 1 trades of the Immunome stock since 2023, according to the Form 4 filled with the SEC. Most recently Bruce bought 42,300 units of IMNM stock worth $249,993 on 2 October 2023.
The largest trade Bruce's ever made was buying 42,300 units of Immunome stock on 2 October 2023 worth over $249,993. On average, Bruce trades about 21,150 units every 0 days since 2023. As of 2 October 2023 Bruce still owns at least 42,300 units of Immunome stock.
You can see the complete history of Bruce Turner stock trades at the bottom of the page.
Bruce's mailing address filed with the SEC is C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011.
Over the last 4 years, insiders at Immunome have traded over $0 worth of Immunome stock and bought 480,004 units worth $5,722,735 . The most active insiders traders include Clay B Siegall, Jean Jacques Bienaime и Michael Rapp. On average, Immunome executives and independent directors trade stock every 84 days with the average trade being worth of $518,362. The most recent stock trade was executed by Jean Jacques Bienaime on 15 August 2024, trading 7,000 units of IMNM stock currently worth $97,580.
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Immunome executives and other stock owners filed with the SEC include: